Stockscreener 앱 받기
12.18
1.67%
0.20
시간 외 거래:
12.18
전일 마감가:
$11.98
열려 있는:
$12.02
하루 거래량:
145.28K
Relative Volume:
0.83
시가총액:
$412.44M
수익:
$59,000
순이익/손실:
$-21.81M
주가수익비율:
-1.1121
EPS:
-10.9518
순현금흐름:
$-18.07M
1주 성능:
-7.66%
1개월 성능:
-7.45%
6개월 성능:
-26.09%
1년 성능:
+3.48%
1일 변동 폭
$11.88
$12.44
1주일 범위
$11.88
$13.47
52주 변동 폭
$9.70
$17.15
Benitec Biopharma Inc Stock (BNTC) Company Profile
명칭
Benitec Biopharma Inc
전화
(510) 780-0819
주소
3940 TRUST WAY, HAYWARD, CA
BNTC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BNTC
Benitec Biopharma Inc
|
12.18 | 405.67M | 59,000 | -21.81M | -18.07M | -10.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-07 | 개시 | TD Cowen | Buy |
| 2024-12-16 | 개시 | H.C. Wainwright | Buy |
| 2024-12-13 | 개시 | Robert W. Baird | Outperform |
| 2024-10-16 | 개시 | Oppenheimer | Outperform |
| 2024-09-12 | 개시 | Guggenheim | Buy |
| 2024-07-22 | 개시 | Leerink Partners | Outperform |
| 2024-06-13 | 개시 | Piper Sandler | Overweight |
| 2020-10-05 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2020-04-20 | 개시 | Ladenburg Thalmann | Buy |
| 2016-02-26 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2015-12-31 | 재확인 | Maxim Group | Buy |
| 2015-09-16 | 재확인 | Maxim Group | Buy |
모두보기
Benitec Biopharma Inc 주식(BNTC)의 최신 뉴스
Benitec Biopharma Limited (NASDAQ:BNTC) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Will Benitec Biopharma Inc stock pay special dividendsJuly 2025 Gainers & AI Driven Stock Movement Reports - moha.gov.vn
Janus Henderson Group PLC's Strategic Acquisition in Benitec Biopharma Inc - GuruFocus
Aug Setups: Is Benitec Biopharma Inc stock resilient to inflationQuarterly Portfolio Summary & High Return Stock Watch Alerts - moha.gov.vn
Wall Street Analysts Predict an 87.48% Upside in Benitec Biopharma (BNTC): Here's What You Should Know - Yahoo Finance
Down 25.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Benitec Biopharma (BNTC) - Yahoo Finance
Benitec Biopharma shareholders approve all proposals at annual meeting By Investing.com - Investing.com Australia
Benitec Biopharma shareholders approve all proposals at annual meeting - Investing.com
Benitec Biopharma Concludes 2025 Annual Stockholders Meeting - TipRanks
Price-Driven Insight from (BNTC) for Rule-Based Strategy - news.stocktradersdaily.com
Can Benitec Biopharma Inc. stock continue upward trendJuly 2025 Momentum & AI Enhanced Execution Alerts - Newser
Risk Check: Can Benitec Biopharma Inc. stock double in next 5 years - BỘ NỘI VỤ
Big Insider Purchases by Carl Icahn, Mario Gabelli, and Others - AOL.com
Franklin Resources Inc. Cuts Stake in Benitec Biopharma Limited $BNTC - MarketBeat
Why Benitec Biopharma Inc. stock could be next big winner2025 Key Lessons & Weekly Momentum Picks - moha.gov.vn
Can Benitec Biopharma Inc. stock double in next 5 yearsJuly 2025 Drop Watch & High Accuracy Swing Entry Alerts - moha.gov.vn
HC Wainwright Has Optimistic Outlook of BNTC FY2026 Earnings - MarketBeat
What is HC Wainwright's Estimate for BNTC Q2 Earnings? - MarketBeat
Q2 Earnings Estimate for BNTC Issued By HC Wainwright - Defense World
BNTC Analyst Rating Maintained but Price Target Lowered to $32 b - GuruFocus
Benitec BioPharma price target lowered to $32 at H.C. Wainwright By Investing.com - Investing.com UK
Benitec Biopharma (NASDAQ:BNTC) Rating Increased to Hold at Wall Street Zen - Defense World
Benitec Biopharma Shares Surge 20% After FDA Grants Fast Track Status for OPMD Gene Therapy - MSN
(BNTC) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
Is Benitec Biopharma Inc. stock a smart buy before Fed meetingWeekly Trade Summary & Low Risk Growth Stock Ideas - newser.com
[Form 4] Benitec Biopharma Inc. Insider Trading Activity - Stock Titan
Pattern recognition hints at Benitec Biopharma Inc. upsideJuly 2025 Final Week & Risk Adjusted Buy and Sell Alerts - newser.com
Benitec Biopharma Limited (NASDAQ:BNTC) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Can Benitec Biopharma Inc. stock sustain market leadershipEarnings Miss & Risk Managed Trade Strategies - newser.com
Benitec Biopharma Limited (NASDAQ:BNTC) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Is Benitec Biopharma Inc. a candidate for recovery play2025 Top Gainers & Trade Opportunity Analysis - newser.com
Is Benitec Biopharma Inc. stock affected by interest rate hikesLong Setup & Reliable Intraday Trade Alerts - newser.com
Strategies to average down on Benitec Biopharma Inc.July 2025 Recap & Technical Buy Zone Confirmations - newser.com
Benitec Biopharma Inc. recovery potential after sell off2025 Buyback Activity & Risk Controlled Stock Alerts - newser.com
Is Benitec Biopharma Inc. stock attractive for growth ETFs2025 Market WrapUp & Risk Controlled Daily Plans - newser.com
Can a trend reversal in Benitec Biopharma Inc. lead to recoveryProfit Target & Community Consensus Trade Alerts - newser.com
Citizens reiterates Market Outperform rating on Benitec BioPharma stock By Investing.com - Investing.com Canada
Real time social sentiment graph for Benitec Biopharma Inc.2025 Market Overview & Fast Moving Market Watchlists - newser.com
Citizens Lifts Benitec Biopharma Inc. (BNTC) Price Target on Topline Results for Oculopharyngeal Muscular Dystrophy Treatment - Finviz
Benitec Biopharma Reports Increased Quarterly Loss Amid Rising Expenses - MSN
Hedge funds investors have a lot riding on Benitec Biopharma Inc. (NASDAQ:BNTC) with 37% ownership - Yahoo Finance
Citizens reiterates Market Outperform rating on Benitec BioPharma stock - Investing.com India
Benitec Biopharma Inc (BNTC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Benitec Biopharma Inc 주식 (BNTC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Mar 31 '25 |
Buy |
12.83 |
16,497 |
211,736 |
8,807,805 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Mar 26 '25 |
Buy |
13.00 |
900,000 |
11,700,000 |
8,793,245 |
| BUCHI J KEVIN | Director |
Feb 27 '25 |
Option Exercise |
3.86 |
51,813 |
199,998 |
103,910 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 23 '24 |
Buy |
10.98 |
27,502 |
301,972 |
7,981,725 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 24 '24 |
Buy |
11.25 |
20,018 |
225,202 |
7,999,455 |
0.36%
1.05%
자본화:
|
볼륨(24시간):